# OnCo record su-weiguo (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/su-weiguo/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "su-weiguo" ;
  schema:name "Weiguo Su"@en ;
  schema:alternateName "苏慰国"@en ;
  schema:description "Weiguo Su led the Shanghai chemistry that produced fruquintinib, savolitinib and surufatinib, three Chinese-discovered cancer pills approved at home and, for fruquintinib, in the US."@en ;
  schema:url <https://onco.cc/people/su-weiguo/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.hutch-med.com/> ;
  onco:tag "china" ;
  schema:jobTitle "CEO and Chief Scientific Officer, Hutchmed" ;
  onco:drugs <https://onco.cc/drugs/fruquintinib/>, <https://onco.cc/drugs/savolitinib/> ;
  onco:companies <https://onco.cc/companies/hutchmed/> .
